ArticleThe Journal of cardiovascular nursing
Symptoms Experienced During the Menopause Transition and Cognition in Older Women With Cardiovascular Disease: Secondary Analyses of the MindMoves Trial.
Article in The Journal of cardiovascular nursing. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundFew studies have included older women with cardiovascular disease (CVD) when examining symptoms experienced during the menopause transition and current cognition.
objectiveTo explore whether symptoms women recalled experiencing during the menopause transition were associated with later life levels of cognitive function and cognition-related serum biomarkers in women with CVD.
methodsThis is a secondary, exploratory, cross-sectional analysis of baseline data from the 197 older women with CVD, who did not have a hysterectomy and removal of both ovaries before their last menstrual period, who participated in a lifestyle intervention to improve cognitive function. Four symptom dimensions experienced during the menopause transition (vasomotor, sexual dysfunction, psychological, and somatic) were identified based on retrospective recall. Cognitive function was assessed using a battery of neuropsychological tests that evaluated 3 memory domains (episodic, semantic, and working). Three cognition-related serum biomarkers were also measured. A series of linear regression models was used to evaluate associations of symptom dimensions with cognitive function and serum biomarkers. Models were adjusted for age, racial/ethnic background, education level, and use of hormone replacement therapy.
resultsFewer somatic symptoms during the menopause transition and ever taking hormone replacement therapy were associated with higher episodic memory, and more sexual dysfunction and younger age were associated with higher working memory. No associations were found for any symptom domains and serum biomarkers in regression models.
conclusionsThese findings may further the understanding of particularly somatic symptoms experienced during the menopause transition that could be precursors to lower cognitive function later in life in women with CVD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.